TMCnet News

Research and Markets: Global Influenza Market 2014-2018 - Emergence of Quadrivalent Vaccines for H1N1 Influenza
[October 31, 2014]

Research and Markets: Global Influenza Market 2014-2018 - Emergence of Quadrivalent Vaccines for H1N1 Influenza


DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/ckndml/global_influenza) has announced the addition of the "Global Influenza Market 2014-2018" report to their offering.

The Global Influenza market to grow at a CAGR of 8.10 percent over the period 2013-2018

Influenza is a contagious respiratory disease caused by influenza viruses. These viruses infect the nose, throat, and lungs causing mild to severe illness. The disease can be fatal in some cases. Elderly people, young children, and people with medical conditions including liver disorders, blood disorders, kidney disorders, chronic lung disease, asthma, and neurodevelopmental and neurological conditions are at a higher risk of getting infected. Influenza vaccines are administered for active immunization against influenza virus. This, in turn, confers protection against influenza disease. Vaccination of high-risk groups prevents unnecessary hospitalizations and premature deaths resulting due to influenza.



One key trend upcoming in this market is the emergence of quadrivalent vaccines for H1N1 influenza, which confer additional protection compared to trivalent vaccines.

According to the report, increase in awareness regarding influenza is one of the major drivers of the market. Lack of awareness regarding the infection, its implications, and available vaccines increases the chances of developing the infection.


Further, the report states that one of the main challenges in the market is the antigenic drift in influenza vaccines. Antigenic drift necessitates the reformulation of existing vaccines in order to sustain the efficacy of these vaccines against circulating viral strains.

To calculate the market size, the report considers the revenue generated through the sales of various vaccines and drugs administered to prevent and treat human infection caused by influenza virus.

Key Vendors

  • AstraZeneca
  • F. Hoffmann-La Roche
  • GlaxoSmithKline plc
  • Novartis
  • Sanofi Pasteur

Key Topics Covered:

  1. Executive Summary
  2. List of Abbreviations
  3. Scope of the Report
  4. Market Research Methodology
  5. Introduction
  6. Disease Overview
  7. Market Landscape
  8. Market Segmentation by Type of Influenza Virus
  9. Global H1N1 Vaccines Market 2013-2018
  10. Market Segmentation by Product Type
  11. Global Influenza Drugs Market
  12. Global Influenza Vaccines Market
  13. Geographical Segmentation
  14. Buying Criteria
  15. Market Growth Drivers
  16. Drivers and their Impact
  17. Market Challenges
  18. Impact of Drivers and Challenges
  19. Market Trends
  20. Trends and their Impact
  21. Vendor Landscape
  22. Key Vendor Analysis

For more information visit http://www.researchandmarkets.com/research/ckndml/global_influenza


[ Back To TMCnet.com's Homepage ]